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Dose escalation by tomotherapy in non-small cell lung cancer 
- early clinical experiences -
Lee, Chang G.; Lee, Ik J.; Cho, Jae H.; Keum, Ki C.; Kim, Yong B.; 
Yoo, Se W.; Suh, Yang K.; Kim, Song Y.; Kim, Gwi E. 
Yonsei University College of Medicine, Seoul, Korea
Purpose: To evaluate treatment responses, acute toxicities according to 
dose escalation by tomotherapy in non-small cell lung cancer(NSCLC).
Materials and Methods: From May 2006 to January 2007, six patients 
underwent tomotherapy for NSCLC at the Dept. of Radiation Oncol-
ogy, Yonsei Cancer Center. Of the 6 patients, 5 were men and 1 was 
woman. Five patients had adenocarcinoma and 1 had squamous cell 
carcinoma. One patient was stage I, 1 stage IIIA, 4 stage IIIB. To-
motherapy was delivered using Tomotherapy Hi-Art System which 
combines IMRT with a helical delivery pattern to deliver radiation in 
accordance with the prescribed treatment plan. The prescribed dose 
was 75-105 Gy(BED mean 91Gy) to gross tumor volume with 2.5-3 
Gy/fr, 50-55 Gy to clinical target volume with 1.8-2Gy/fr. Induction 
chemotherapy was performed in 5 patients with 3-8 cycles. Concur-
rent chemo-radiotherapy with taxotere or cisplatin was delivered in 5 
patients. 
Results: The response rate after tomotherapy was partial remission in 
5 patients and stable disease in 1. Two patient showed grade II acute 
esophagitis, 1 grade I, 3 grade 0. There was no grade III/IV hemato-
logic toxicity and no symptomatic radiation pneuminitis.
Conclusion: In spite of short clinical experiences, good response rate 
and safe dose escalation without signiﬁcant treatment related acute 
toxicities from sparing of critical normal structures for NSCLC were 
achieved with helical tomotherapy. 
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Early Experience of Helical Tomotherapy for Lung Cancer with 
Multiple Metastatic Lesions
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Jinsil; Suh, Chang Ok; Kim, Gwi Eon; Jeong, Kyungkeun; Kim, Yong 
Bae 
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Purpose: The objective of this study is to evaluate efﬁcacy of helical 
tomotherapy for lung cancer with multiple metastatic lesions
Methods and Materials: Nine non-small cell lung cancer patients 
with multiple metastatic lesions were treated with tomotherapy from 
April 2006 to January 2007. Doses of 50-70 Gy with 2.12-6 Gy/frac-
tion for gross target volume were applied. The V20 (the volume of lung 
irradiated to 20 Gy or above) be kept < 30% to maintain a low risk 
of radiation pneumonitis. Among the patients, 5 patients had separate 
metastatic pulmonary tumor nodules in the ipsilateral or contralateral 
nonprimary tumor lobe of the lung, 4 patients had bone metastasis, 1 
patient had brain metastasis, and 1 patient had adrenal gland metastasis. 
Treatment planning was performed using Tomotherapy Hi-Art System, 
version 2.0 (TomoTherapy, WI, USA), applying simultaneously 
integrated boost technique. Subjective pain response to treatment was 
assessed using the Wisconsin Brief Pain Questionnaire, and the morbid-
ity was evaluated by the Common Terminology Criteria for Adverse 
Events v3.0.
Results: Seven patients received various chemotherapeutic regimens 
before tomotherapy. With regard to pain palliative effect, tomotherapy 
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relieved pain in 83.3% of symptomatic patients (5/6). Five patients with 
separate metastatic pulmonary nodules showed multiple hematogenous 
lung metastases within 2 months follow up. However, multiple local 
control rates was 75% (3/4) in the primary lung cancer patients with ex-
trapulmonary metastatic lesions, and only one patient recurred as hema-
togenous lung metastases at 8 months follow up. The Grade II toxicities 
included skin reaction in 1 patient, and esophagitis in 2 patients. The 
main GIII toxicity was leucopenia in 2 patients. 
Conclusions: Helical tomotherapy was effective for symptom pallia-
tion by multiple local controls in lung cancer patients with multiple 
extrapulmonary metastatic diseases. However, patients with separate 
multiple pulmonary nodules showed no beneﬁt for tomotherapy.
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Optimization of lung IMRT Treatment plans using a beam 
direction and virtual organ delineation
Lee, Suk1 Cho, Kwang Hwan2 Shin, Hun Joo2 Lee, Sang Hoon2 Huh, 
Hyundo2 Cho, Samjoo2 Lim, Sangwook2 Jang, Jisun2 Shin, Dongho3 
Park, Young Je1 Lee, Nam Kwon1 Yang, Dae Sik1 Kim, Chul Yong1 
1 Department of Radiation Oncology, College of Medicine, Korea 
University, Seoul, Korea 2 Department of Medical Physics, Kyonggi 
University, Seoul, Korea 3 Research Institute and Hospital, National 
Cancer Center, Ilsan, Korea 
Background: We introduce a pulmonary cancer patient IMRT process, 
the radiotherapy it confronts to the possibility of the beam for the opti-
mization of plan and the use of direction, the VOD and dose restriction 
factor it evaluates with the place where it minimizes the dose which is 
used in the lung and the heart it evaluates the useful characteristic of 
the IMRT techniques which it uses. 
Methods: The tumor permeated to the mediastinum and during rela-
tively long time it did 5 person lung cancer patients where the error 
which is located small in the object. The patient immobilization devices 
to side overlook maintains the upper half of body and ﬁxes the location 
of the arm, the belt uses. Then it press the epigastrium, it was decreased 
moving internal organs due to a respiratory movement. The treatment 
plans, the beam number and direction used 5,7,9 portal (from 200 to 
160, equispaced ﬁeld), 4 portal (anterior, posterior, bilateral poste-
rior oblique ﬁeld) and an-isotropic 7, 9 portal (non-equispaced ﬁeld, 
arbitrary ﬁeld). The dose restriction is based on the reference and it set, 
appropriately, virtual organ used. So, we got the therapy plan result 
which had become optimization. The radiotherapy plans evaluated dose 
volume histogram (DVH), used a isodose curve and the dose-statistics. 
Specially, before and after setting up the virtual organ delineation and it 
analyzed a kindness data and it conﬁrmed the useful characteristic. 
Results: Methods of equispace 9 portal IMRT and non-equispace 7 
portal IMRT are good results within 20% by PVT dose homogeneity, 
mean lung dose and V20, V25. And getting same good result by setup 
the virtual organ delineation. Also, know the possibility of complement 
error during treatment by using clinical draw up lung cancer IMRT 
protocol.
Conclusions: We draw up the protocol, it will be able to use in lung 
cancer IMRT, and know the possibility of getting the optimization of 
treatment plans with set of the virtual organ delineation which is ap-
propriate and the irradiation plans. 
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Surgery versus radiosurgery for single synchronous brain 
metastasis from non-small cell lung cancer
Li, Hui; Hou, Shengcai; Hu, Bin 
Department of Thoracic Surgery, Beijing Chaoyang Hospital, Capital 
Medical University, Beijing, China
Objective: The aim of this study is to compare the effectiveness of 
surgery with that of radiosurgery for patients with a single synchronous 
brain metastasis from successfully treated non-small cell lung cancer. 
Method: Between 1995 and 2002, ﬁfty-three patients underwent resec-
tion of both a primary non-small cell lung cancers and the associated 
single brain metastasis. There were 33 men and 20 women with a mean 
age of 57 years (range, 32-85 years). At the time of diagnosis,forty-two 
patients experienced lung cancer related symptoms, whereas 11 patients 
experienced brain metastases-related symptoms. Forty-two patients had 
ungone thoracic surgery ﬁrst, and 11 patients had undergone neurosur-
gery or radiosurgery ﬁrst. Pneumonectomy was performed in 9 out of 42 
patients (21.4%), lobectomies in 30 (71.4%), and wedge resection in 3 
